Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide populationMargherita Rimini, Min-Su Kang, Jessica Lucchetti et al.|European Journal of Cancer|2024Cited by 47
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide populationFederica Lo Prinzi, Monica Niger, Francesca Salani et al.|The Oncologist|2024Cited by 10
Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: A Large Real-Life Worldwide PopulationMargherita Rimini, Min-Su Kang, Lorenzo Fornaro et al.|SSRN Electronic Journal|2024Cited by 3
151P A new prognostic index for patients with advanced biliary tract cancer treated with cisplatin, gemcitabine and durvalumabM. Persano, Lorenzo Fornaro, L. Antonuzzo et al.|Annals of Oncology|2024Cited by 0
77P A new prognostic index for patients with advanced BTC treated with cisplatin, gemcitabine and durvalumabM. Persano, A. Casadei Gardini, Lorenzo Fornaro et al.|Immuno-Oncology Technology|2024Cited by 0